Product Overview
JNJ-26076713 | T27670 | TargetMol Chemicals
CAS: 669076-03-3
Smiles: OC(=O)C[C@H](CC1CCN(CC1)C(=O)CCC1=CC=C2CCCN=C2N1)[C@H]1CNc2ccccc2C1
Formula: C29H38N4O3
Pathway: N/A
Target: N/A
Receptor: N/A
Bioactivity: JNJ-26076713, an orally active alpha V integrin antagonist, represents a potential therapeutic candidate for the treatment of macular edema, age-related macular degeneration, and proliferative diabetic retinopathy.
Molecular Weight: 490, 648
